SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Frohnert PP, Sheps SG. Long-term follow-up study of periarteritis nodosa. Am J Med 1967; 43: 814.
  • 2
    Bradley JD, Brandt KD, Katz BP. Infectious complications of cyclophosphamide treatment for vasculitis. Arthritis Rheum 1989; 32: 4553.
  • 3
    Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 1980; 55: 14655.
  • 4
    Cacoub P, Le Thi Huong D, Guillevin L, Godeau P. Les causes de mortalité au cours des vascularites systémiques du groupe de la périartérite noueuse: analyse d'une série de 165 malades. Ann Med Interne (Paris) 1988; 139: 38190.
  • 5
    Exley AR, Carruthers DM, Luqmani RA, Kitas GD, Gordon C, Janssen BA, et al. Damage occurs early in systemic vasculitis and is an index of outcome. QJM 1997; 90: 3919.
  • 6
    Fauci AS, Katz P, Haynes BF, Wolff SM. Cyclophosphamide therapy of severe necrotizing vasculitis. N Engl J Med 1979; 301: 2358.
  • 7
    Leib ES, Restivo C, Paulus HE. Immunosuppressive and corticosteroid therapy of polyarteritis nodosa. Am J Med 1979; 67: 9417.
  • 8
    Guillevin L, Jarrousse B, Lok C, Lhote F, Jaïs JP, Le Thi Huong Du D, et al, and the Cooperative Study Group for Polyarteritis Nodosa. Longterm follow-up after treatment of polyarteritis nodosa and Churg-Strauss angiitis with comparison of steroids, plasma exchange and cyclophosphamide to steroids and plasma exchange: a prospective randomized trial of 71 patients. J Rheumatol 1991; 18: 56774.
  • 9
    Guillevin L, Fain O, Lhote F, Jarrousse B, Le Thi Huong D, Bussel A, et al. Lack of superiority of steroids plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome: a prospective, randomized trial in 78 patients. Arthritis Rheum 1992; 35: 20815.
  • 10
    Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Généreau T, et al. Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis: a prospective, randomized trial in sixty-two patients. Arthritis Rheum 1995; 38: 163845.
  • 11
    Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, et al. Polyarteritis nodosa related to hepatitis B virus: a prospective study with long-term observation of 41 patients. Medicine (Baltimore) 1995; 74: 23853.
  • 12
    Gayraud M, Guillevin L, Cohen P, Lhote F, Cacoub P, Deblois P. Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. Br J Rheumatol 1997; 36: 12907.
  • 13
    Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978; 89: 66076.
  • 14
    Masi AT, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094100.
  • 15
    Lightfoot RW Jr, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, et al. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 108893.
  • 16
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 18792.
  • 17
    Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999; 42: 42130.
  • 18
    Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998; 129: 34552.
  • 19
    Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 1728.
  • 20
    Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 1994; 87: 6718.
  • 21
    Luqmani RA, Exley AR, Kitas GD, Bacon PA. Disease assessment and management of the vasculitides. Baillieres Clin Rheumatol 1997; 11: 42247.
  • 22
    Hagen EC, Daha MR, Hermans J, Andrassy K, Csernok E, Gaskin G, et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis: EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53: 74353.
  • 23
    Mueller ME. Some continuous Monte Carlo methods for the Dirichlet problem. Ann Math Stat 1956; 27: 56989.
  • 24
    Kerjosse R, Tamby I. La situation démographique en France en 1994: mouvement de la population. INSEE (Institut National de la Statistique et des Etudes Economiques); 1995. Internal Report 12945.
  • 25
    Kaplan E, Meier P. Non parametric estimation for incomplete information. J Am Stat Assoc 1958; 53: 45781.
  • 26
    Peto R, Pike MC. Conservatism of the approximation (O-E)2-E in the logrank test for survival data or tumor incidence data. Biometrics 1973; 29: 57984.
  • 27
    Cox DR. Regression models and lifetable. J R Stat Soc B 1972; 34: 187200.
  • 28
    Sen RP, Walsh TE, Fisher W, Brock N. Pulmonary complications of combination therapy with cyclophosphamide and prednisone. Chest 1991; 99: 1436.
  • 29
    Baudoin C. Epidémiologie présente et future des ostéoporoses. Rev Prat 1995; 45: 108995.
  • 30
    Gross WL. New concept in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol 1999; 11: 416.
  • 31
    Réseau Français des Registres de Cancers FRANCIM, 37 allée Jules Guesde, 31073 Toulouse, France.
  • 32
    Stillwell TJ, Benson RC Jr, DeRemee RA, McDonald TJ, Weiland LH. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum 1988; 31: 46570.
  • 33
    Stillwell TJ, Benson RC. Cyclophosphamide-induced hemorrhagic cystitis: a review of 100 patients. Cancer 1988; 61: 4517.
  • 34
    Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener's granulomatosis: an analysis of 158 patients. Ann Intern Med 1992; 116: 48898.
  • 35
    Talar-Williams C, Hijazi YM, Walther MM, Lineham WM, Hallahan CW, Lubensky I, et al. Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener's granulomatosis. Ann Intern Med 1996; 124: 47784.